CEACAM5 and malignant colon neoplasm: High serum CEA level (⩾5 ng ml–1) was observed in 85 (60.3%) of preoperative and 47 (33.3%) of postoperative colon cancer patients, and persistent postoperative CTCs were detected in 51 (36.2%) of 141 colon cancer patients.